The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer

BACKGROUND: Trastuzumab treatment for women with HER2-positive breast cancer (BC) resulted in the significant improvement of both relapse free survival (RFS) and overall survival (OS). However, many women who are classified as HER2-positive do not respond. Many studies have focused on the role of so...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Toomey, Sinead, Madden, Stephen F., Furney, Simon J., Fan, Yue, McCormack, Mark, Stapleton, Carragh, Cremona, Mattia, Cavalleri, Gianpiero L., Milewska, Malgorzata, Elster, Naomi, Carr, Aoife, Fay, Joanna, Kay, Elaine W., Kennedy, Susan, Crown, John, Gallagher, William M., Hennessy, Bryan T., Eustace, Alex J.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342757/
https://ncbi.nlm.nih.gov/pubmed/27776352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12782
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares